Cited in:


This article has been cited by:

  1. 1
    C. Politis, E. Hassapopoulou, P. Halkia, A. Kourakli, A. Mougiou, E. Zervou, E. Kleronomos, K. Sfyridaki, C. Pappa, I. Tsoumari, I. Lafiatis, L. Kavallierou, M. Parara, C. Richardson, Managing the patient with haemoglobinopathy and multiple red cell antibodies, ISBT Science Series, 2016, 11,
  2. 2
    Seema Kacker, Paul M. Ness, William J. Savage, Kevin D. Frick, R. Sue Shirey, Karen E. King, Aaron A.R. Tobian, Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients, Transfusion, 2014, 54, 1
  3. 3
    Seema Kacker, Paul M. Ness, William J. Savage, Kevin D. Frick, R. Sue Shirey, Karen E. King, Aaron A.R. Tobian, Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease, Transfusion, 2014, 54, 8
  4. 4
    Marion E. Reid, Christine Halter Hipsky, Kim Hue-Roye, Carolyn Hoppe, Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease, Blood Cells, Molecules, and Diseases, 2014, 52, 4, 195


  5. You have free access to this content5
    Elliott Vichinsky, Lynne Neumayr, Sean Trimble, Patricia J. Giardina, Alan R. Cohen, Thomas Coates, Jeanne Boudreaux, Ellis J. Neufeld, Kristy Kenney, Althea Grant, Alexis A. Thompson, Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME), Transfusion, 2014, 54, 4
  6. 6
    Scott T. Miller, Hae-Young Kim, Debra L. Weiner, Carrie G. Wager, Dianne Gallagher, Lori A. Styles, Carlton D. Dampier, Susan D. Roseff, Red blood cell alloimmunization in sickle cell disease: prevalence in 2010, Transfusion, 2013, 53, 4
  7. 7
    Angela Treml, Karen E. King, Red blood cell alloimmunization: lessons from sickle cell disease, Transfusion, 2013, 53, 4
  8. 8
    Weili Bao, Hui Zhong, Xiaojuan Li, Margaret T. Lee, Joseph Schwartz, Sujit Sheth, Karina Yazdanbakhsh, Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major, American Journal of Hematology, 2011, 86, 12
  9. 9
    Loren D. Fast, Gilbert DiLeone, Susanne Marschner, Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation, Transfusion, 2011, 51, 7